Co-founder of Ilya Pharma shortlisted for pioneering achievements in bringing game-changing innovation to clinical proof of concept.
Twenty-one of the most talented and inspiring women entrepreneurs in Europe and beyond are in the shortlist for the EU Prize for Women Innovators 2020. The prize celebrates the outstanding achievements of female entrepreneurs running innovative companies and is funded by the EU’s Horizon 2020 programme for research and innovation. This year’s finalists are pioneering game-changing innovations across a wide range of industries and help combat global challenges. The winners of the EU Prize for Women Innovators 2020 will be announced at the European Research and Innovation Days taking place on 22-24 September 2020. At the same event, the Commission will award the European Capital of Innovation 2020, the EIC Horizon Prize for Affordable High-Tech for Humanitarian Aid, and the Horizon Impact Award 2020.
Ilya Pharma joins the ranks of globally recognized brands including Rebiotix, later acquired by Ferring, the first company in microbiome to recruit to a phase III trial. About Springboard Enterprises: Springboard Enterprises' mission is to accelerate the growth of entrepreneurial companies led by women through access to essential resources and a global community of experts. Since 2000, over 800 Springboard portfolio companies seeking investment of financial and human capital for product development and expansion have created $20 Billion in value via equity investments, 20 IPOs and 200 acquisitions by strategic partners. Springboard entrepreneurs are transforming industries.
Ilya Pharma receives Bio-X grant to complete preclinical work for novel IBD chemokine-based gene therapy candidates
Pod cast Discovery matters, episode 13. Scratched knees, smelly yogurt, and speedy wound healing
Evelina Vågesjö, CEO and cofounder Ilya Pharma, Hans Genee, Lauri Sippola and Erik Gatenholm have all been recognized by MIT Technology Review European Innovators under 35
Ilya Pharma interviewed by the real estate company Vasakronan, facilitating growth of companies in Uppsala Science Park
We advocate more pharmaceutical products to be tested in clinical trials to meet relevant efficacy endpoints and deliver clinical value in different wound segments.